Proteinase K Market Size

Proteinase K Market Size

The global proteinase K market size was valued at around USD 1.3 billion in 2023 and is estimated to grow at 7.5% CAGR from 2024 to 2032. The increasing prevalence of chronic and infectious diseases, along with advancements in biotechnology, is driving the growth of the market.

To get key market trends

  Download Free Sample

Chronic and infectious diseases are major drivers, as proteinase K plays a critical role in molecular diagnostics and research related to these conditions. Contributing factors to the rise in chronic diseases include an aging population, sedentary lifestyles, and poor dietary habits, leading to conditions such as cardiovascular diseases, diabetes, and cancer. Meanwhile, the spread of infectious diseases is driven by urbanization, global travel, and the rise of antimicrobial resistance. According to the World Health Organization (WHO), non-communicable diseases account for nearly 71% of all global deaths, while infectious diseases like tuberculosis, HIV, and emerging viruses remain significant public health concerns.

Consequently, the demand for advanced diagnostic tools and molecular studies is growing, heavily relying on proteinase K for its crucial role in the isolation and purification of DNA and RNA in clinical and research settings. Proteinase K, a broad-spectrum serine protease enzyme, is widely used in molecular biology for digesting proteins and removing contaminants such as nucleases. Its effectiveness in breaking down proteins in samples for DNA and RNA extraction makes it indispensable for applications like genomic analysis, in situ hybridization, and mitochondria isolation.